SCHEMBL12770853

SCHEMBL12770853

CC(C)[C@H](C)/C=C\C(O)[C@H]1OC(C)(C)O[C@H]1CCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12770854 0.89 — —
SCHEMBL13156627 0.85 — —
SCHEMBL12770790 0.85 — —
SCHEMBL12552178 0.79 — —
SCHEMBL15385406 0.78 — —
SCHEMBL15385407 0.78 — —
SCHEMBL12553919 0.78 — —
SCHEMBL13904131 0.78 SMYD2 (0.37) CYP3A4
SCHEMBL13904130 0.78 SMYD2 (0.37) CYP3A4
SCHEMBL12772093 0.78 SMYD2 (0.37) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915306-B2 For therapy of inflammatory or autoimmune disorders EISAI CO., LTD. (JP) 2011-03-29 — — US disclosed
US-7799827-B2 Macrocyclic compounds useful as pharmaceuticals EISAI CO., LTD. (JP) 2010-09-21 — — US disclosed
Send feedback